PharmaVoice
1,319 FOLLOWERS
PharmaVoice offers multiple channels for brand enhancement, thought-leadership positioning, and lead generation to the pharma, biotech, and med device industry.
PharmaVoice
21h ago
The latest version of The Biosecure Act working its way through Congress could make waves in the U.S. biotech industry ..read more
PharmaVoice
21h ago
By developing ADCs that bind more directly to the target, Mythic Therapeutics believes its technology could deliver a step change for efficacy and safety ..read more
As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’
PharmaVoice
21h ago
To lower drug prices, lawmakers are turning to the drug patent system to outlaw some common practices — but a former patent agency director says it’s the wrong way to go ..read more
PharmaVoice
4d ago
As Novo Nordisk aims to secure its manufacturing foothold for GLP-1s, regulators are digging for clues of anti-competitive behavior ..read more
PharmaVoice
4d ago
A partnership between the cell therapy delivery specialist Portal Biotechnologies and precision robotics maker Multiply Labs could bring the manufacturing bottleneck under control, the CEOs said ..read more
PharmaVoice
5d ago
Supply of GLP-1 medications falls well short of demand, and oral versions of the drugs loom over Eli Lilly and Novo Nordisk’s dominance.
..read more
PharmaVoice
1w ago
The stage is set for potential blockbuster-level showdowns targeting these three indications ..read more
PharmaVoice
1w ago
Promises made by pharma and biotech companies show confidence in the future of their business and dedication to financial success, R&D and environmental protection ..read more
PharmaVoice
1w ago
Companies like UpScriptHealth led the charge with online prescriptions decades ago, and now the industry is catching on to solve some of healthcare’s most pressing issues ..read more
PharmaVoice
1w ago
Direct-to-consumer platforms offer consumers an online path to sourcing popular medications, but some therapeutic areas may be better suited for the business model.
..read more